Stock CLPT CLEARPOINT NEURO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings ClearPoint Neuro, Inc.

Equities

CLPT

US18507C1036

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
6.21 USD +2.48% Intraday chart for ClearPoint Neuro, Inc. -2.97% -8.54%
May. 07 ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M MT

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • Revenue estimates are regularly revised downwards for the current and coming years.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CLEARPOINT NEURO, INC. Stock ClearPoint Neuro, Inc.
-8.54% 170M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+10.22% 223B
B
DANAHER CORPORATION Stock Danaher Corporation
+12.99% 194B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+18.09% 141B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+28.66% 109B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.09% 64.85B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.70% 52.7B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+6.68% 51.77B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+8.29% 44.12B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.60% 36.21B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLPT Stock
  4. Ratings ClearPoint Neuro, Inc.